You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

treatment of hepatocellular cancer after first metastasis

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Postoperative Peritoneal Metastasis After Hepatocellular

Completed
  • Peritoneal Metastasis
  • Peritoneal Metastasis
  • Wuhan, Hubei, China
    Tongji Hospital, Tongji Medical College, Huazhong University of
Oct 25, 2023

HCC - Hepatocellular Carcinoma, Metastatic Cancer, Metastatic Tumor Trial in France (Ipilimumab Injection, Atezolizumab

Not yet recruiting
  • HCC - Hepatocellular Carcinoma
  • +2 more
  • Ipilimumab Injection
  • +2 more
  • Créteil, France
  • +7 more
Dec 27, 2022

Hepatocellular Carcinoma Trial in Seoul (Lenvatinib)

Recruiting
  • Hepatocellular Carcinoma
  • Seoul, Korea, Republic of
    Asan Medical Center
Nov 14, 2023

Hepatocellular Carcinoma, Peritoneal Metastasis, Hyperthymic Trial in Chengdu (mitomycin C-based hyperthermic intraperitoneal

Recruiting
  • Hepatocellular Carcinoma
  • +3 more
  • mitomycin C-based hyperthermic intraperitoneal chemotherapy
  • Chengdu, Sichuan, China
    West China Hospital
Sep 14, 2022

Hepatocellular Carcinoma, Liver Metastases, Cholangiocarcinoma Trial in United States (STP705)

Active, not recruiting
  • Hepatocellular Carcinoma
  • +2 more
  • Scottsdale, Arizona
  • +4 more
Dec 13, 2022

Pancreatic Cancer, Breast Cancer, Hepatocellular Carcinoma Trial in Houston (Piflufolastat F18)

Recruiting
  • Pancreatic Cancer
  • +2 more
  • Piflufolastat F18
  • Houston, Texas
    MD Anderson Cancer Center
Nov 28, 2022

Hepatocellular Carcinoma, Hepatocellular Cancer, Metastatic Pancreatic Cancer Trial run by the NCI (nivolumab, tadalafil, oral

Completed
  • Hepatocellular Carcinoma
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

Breast Cancer, Oligometastasis, Metastatic Breast Cancer Trial in Tokyo (Systemic therapy for 12 weeks after primary

Recruiting
  • Breast Cancer
  • +2 more
  • Systemic therapy for 12 weeks after primary registration
  • +3 more
  • Tokyo, Japan
    Tokyo Medical and Dental Univetsity
Nov 15, 2023

Hepatocellular Carcinoma, Transcatheter Arterial ChEmoembolization, Regorafenib Trial in Guangzhou (TACE, Regorafenib)

Recruiting
  • Hepatocellular Carcinoma
  • +2 more
  • Guangzhou, Guangdong, China
    FirstSunYetSen
Apr 12, 2023

Advanced Cholangiocarcinoma, Advanced Hepatocellular Carcinoma, Advanced Malignant Solid Tumor Trial in Los Angeles (Biospecimen

Recruiting
  • Advanced Cholangiocarcinoma
  • +6 more
  • Biospecimen Collection
  • +3 more
  • Los Angeles, California
  • +1 more
Mar 31, 2023

Unrescetable Hepatocellular Carcinoma Trial in Tianjin (HAIC+Durvalumab+Tremelimumab+Bevacizumab)

Not yet recruiting
  • Unrescetable Hepatocellular Carcinoma
  • Tianjin, Tianjin, China
    Tianjin Cancer Hospital Airport Hospital
May 16, 2023

Hepatocellular Carcinoma, Transcatheter Arterial Chemoembolization, Pain Trial in Nanjing (Oxycodone, Sufentanil)

Recruiting
  • Hepatocellular Carcinoma
  • +3 more
  • Nanjing, Jiangsu, China
    The First Affiliated Hospital with Nanjing Medical University
Sep 15, 2023

Unrescetable Hepatocellular Carcinoma Trial in Tianjin (HAIC+Cadonilimab+Bevacizumab)

Not yet recruiting
  • Unrescetable Hepatocellular Carcinoma
  • Tianjin, Tianjin, China
    Tianjin Cancer Hospital Airport Hospital
Apr 7, 2023

Advanced Adult Hepatocellular Carcinoma Trial in Chicago, Ann Arbor, Dallas (Cabozantinib)

Recruiting
  • Advanced Adult Hepatocellular Carcinoma
  • Chicago, Illinois
  • +3 more
Aug 15, 2022

Melanoma, Non-small Cell Lung Carcinoma (NSCLC), Renal Cell Carcinoma (RCC) Trial in Gainesville, Jacksonville (LITT +

Recruiting
  • Melanoma
  • +14 more
  • LITT + Pembrolizumab
  • Gainesville, Florida
  • +1 more
Aug 22, 2022

Recurrence and Metastasis of Hepatocarcinoma Following Local

Recruiting
  • Hepatocarcinoma
    • Guangzhou, Guangdong, China
    • +16 more
    Dec 22, 2022

    Early Metastasis in Cervical Cancer Patients After Radiotherapy

    Not yet recruiting
    • Cervical Cancer
    • +4 more
    • external pelvic beam radiotherapy (EBRT) followed by individualized high-dose-rate intracavitary brachytherapy (HDR-ICBT)
    • Fuzhou, Fujian, China
      Fujian Cancer Hospital
    Oct 21, 2023

    Cancer of Pancreas Trial in Cairo (Capecitabine, follow up)

    Recruiting
    • Cancer of Pancreas
    • Cairo, Egypt
    • +2 more
    Sep 30, 2022

    Peritoneal Metastasis for Gastric Cancer Based on Radiomics

    Recruiting
    • Gastric Cancer
    • Peritoneal Metastases
    • Peritoneal metastasis status ascertainment
    • Beijing, China
    • +12 more
    Feb 12, 2023

    Hepatocellular Carcinoma Trial in Hangzhou (PM8002, FOLFOX regimen)

    Recruiting
    • Hepatocellular Carcinoma
    • PM8002
    • FOLFOX regimen
    • Hangzhou, Zhejiang, China
      Cancer Hospital of The University of Chinese Academy of Sciences
    May 19, 2023

    Liver Metastasis Colon Cancer Trial in Guangzhou (TACE and HAIC Combined With Regorafenib)

    Not yet recruiting
    • Liver Metastasis Colon Cancer
    • TACE and HAIC Combined With Regorafenib
    • Guangzhou, Guangdong, China
      the first affiliated hospital, Sun-Yat sen university
    Oct 2, 2023

    Hepatitis B Virus Reactivation:Cautionary Event After Liver

    Completed
    • Liver Transplant; Complications
    • Diagnosis of postoperative recurrence of liver cancer
    • (no location specified)
    Oct 27, 2023

    Hepatocellular Carcinoma, NSCLC Metastatic, Liver Metastases Trial in Toronto (Atezolizumab, Bevacizumab)

    Recruiting
    • Hepatocellular Carcinoma
    • +2 more
    • Toronto, Ontario, Canada
      Princess Margaret Cancer Centre
    Jan 8, 2023

    Hepatocellular Carcinoma Trial in Beijing (1mg NWRD06 administered by electroporation, 4mg NWRD06 administered by

    Recruiting
    • Hepatocellular Carcinoma
    • 1mg NWRD06 administered by electroporation
    • +2 more
    • Beijing, China
      Cancer Hospital, Chinese Academy of Medical Sciences
    Oct 15, 2023

    Hepatocellular Cancer Trial in Shanghai (Anlotinib;Toripalimab)

    Recruiting
    • Hepatocellular Cancer
    • Shanghai, Shanghai, China
      Eastern hepatobilliary surgery hospital
    Jul 7, 2022